One fact speaks for itself: to date, just under 300,000 patients have been helped using AngioJet technology. The AngioJet system works. In the U.S. alone, 95 percent of top U.S. coronary labs have the AngioJet system. In total, there are more than 1,672 systems installed across the nation. That's an 11-percent increase from fiscal 2005, and is a testament to the medical community's belief in our technology.

With the anticipated fiscal 2007 launch of our Ultra Console, Possis' base of installed drive units will effectively facilitate transition to the new Console, which offers far greater ease of use for the customer, and increased flexibility to support future catheter designs. Combined with the expected launch of new catheters and other products, we are where we need to be to stay ahead.

Moreover, Possis leads, clearly, in all three of its primary market areas - coronary, peripheral arterial and AV access. With our broad geographic footprint, solid financial and operational infrastructure, and future market potential, we're poised to maximize the emerging opportunities to treat DVT and PE, which afflict over 600,000 people in the U.S. every year, as well as ischemic stroke.